[关键词]
[摘要]
欧洲药物警戒风险评估委员会(PRAC)于2018年2月8日发布了有关氟吡汀撤市评估报告。人用药品相互承认和分散程序协调小组(CMDh)于2018年3月21日批准了这项报告。EMA于2018年3月23日宣布撤销含有氟吡汀药品的上市许可决定。详细介绍PRAC的该报告,期待对认识氟吡汀的肝脏毒性和受益-风险以及决定我国是否也将其撤市有帮助。
[Key word]
[Abstract]
The Pharmacovigilance Risk Assessment Committee (PRAC) of European Medicines Agency (EMA) issued an assessment report on the withdrawal of flupirtine on February 8,2018.CMDh approved the report on March 21,2018.EMA announced its decision to revoke the marketing license of the drug containing flupirtine on March 23,2018.A detailed introduction to the PRAC report is expected to help identify hepatic toxicity and benefit-risk associated with flupirtine as well as determine whether China will remove it from the market.
[中图分类号]
[基金项目]